Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.
about
Functional neuroimaging in Parkinson's diseasePREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline resultsThe diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiologyEnlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.Neuroimaging in pre-motor Parkinson's diseasePresynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia.Neuroimaging: current role in detecting pre-motor Parkinson's disease.Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsOlfactory loss in Parkinson's disease.Olfactory dysfunction in LRRK2 G2019S mutation carriersParkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.The relationship between cerebral Alzheimer's disease pathology and odour identification in old age.Biomarkers in Parkinson's disease.Target Selection Recommendations Based on Impact of Deep Brain Stimulation Surgeries on Nonmotor Symptoms of Parkinson's DiseaseSleep and non-motor symptoms in Parkinson's disease.Classical Parkinson disease versus Parkinson complex--reflections against staging and in favour of heterogeneity.Role of homocysteine in the treatment of Parkinson's disease.Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients.Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.Olfactory dysfunction as a diagnostic marker for Parkinson's disease.DIMETER: a haptic master device for tremor diagnosis in neurodegenerative diseases.Imaging dopamine transporters in Parkinson's disease.Olfaction as a biomarker in Parkinson's disease.Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD.Biomarkers for trials of neuroprotection in Parkinson's disease.Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features.Dementia with Lewy bodies: early diagnostic challenges.What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.Olfaction deterioration in cognitive disorders in the elderly.Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.Modern treatment in Parkinson's disease, a personal approach.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory systemHyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study.Prodromal non-motor symptoms of Parkinson's disease.
P2860
Q27013767-196B7C33-02FB-4912-BF87-2D69E26F107CQ30564071-21C33315-06EC-4BB8-B307-A86FAD605C41Q30635471-8C173553-7286-4E74-A508-EEB6A3670BE2Q33603777-54FA32AC-7FE2-437E-8B64-D55502A55B93Q33632441-9876E3FB-A9E8-499A-A54C-4F0D3BD25BFBQ33676222-5D08DF06-ED51-428D-9A06-09F13B1D3EEEQ33731267-09ED794E-8CA5-48E8-A9C9-6447BA6FAC93Q34100703-02C8186D-B265-4021-962A-D3E184AB6C2CQ34234625-FFD5269E-D934-4AE5-ADDF-29820DCAEA2AQ34463276-C90BB6D5-CDB3-48ED-80F7-B90EB65384BCQ34861140-DCB4BDE0-8806-45D4-8110-0442DC0F8B18Q35028848-6C4C11AF-E63A-4509-9B9D-06B6A9370454Q35119617-D2FC19EE-1B64-4DCD-AD20-E2A00E61545BQ35614156-818069B6-8670-42A0-8852-A3DFD7E7A998Q36227293-9C92C121-0D4F-49EE-A338-264235D4B592Q36511295-3EB17128-5F34-465A-9B31-83721F339BE5Q36701655-800CBDDD-8056-4CB5-B01B-BDB37D334FC2Q36725295-4FA42F8C-12D7-4623-90FB-EDE77CD7EF2CQ36861710-89D9BE82-A2F6-42E8-ABEB-D802CFDFC805Q37174063-A997CEFA-0B53-47D6-A786-112410DD5BEEQ37466992-DB2A9E1A-72C6-4F66-A826-A4001B345F88Q37507963-EE5A6888-418D-45C1-AE74-ADEB09531CBEQ37641997-791704BD-F5AD-46C8-B0C7-6FD81A01B310Q37731026-416285EA-9C4E-4F1D-94CA-C31EC8799C1FQ37800096-51F6B0A0-4D9B-41E7-AE7C-ACB623DED408Q37800097-26BED39E-7F3A-494C-BCB5-BE04DC3371ECQ37824440-FFB9B3C3-DE01-44A8-A91C-8BB669C9F6C2Q37864239-BC11A324-81CE-486C-9F6B-03D4B5591C27Q38003065-EBA98812-ECC2-4F27-A97B-A7E280324357Q38029716-30BDDDFE-CA34-4A5C-A93B-AEE5E3CDFEA4Q38038544-CB893661-92E5-418A-AC1F-0495742C313BQ38123748-F42FA212-F916-4DC9-A151-4C4945594729Q38126115-BDCC8483-1202-4F91-87FB-B9EFB479BA44Q38492560-967C08B1-758F-4A5E-B682-FD724A91046CQ38500010-DEA98BA9-AB19-4AD8-813F-670ADC343357Q38501869-8CE88377-B7B5-45D5-AAA8-68961468653FQ38570529-064B2077-09BB-4E7A-A1D0-A0A85E626A66Q38752945-3E59FCDD-26AF-4DB6-A396-F07A319EEA3FQ39989016-B2021FE1-3D71-4BFC-8CA1-4EACFCBAA4CEQ40247459-F88694F6-21A1-4D0C-A4A2-9DA58DF780D2
P2860
Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Detection of presymptomatic Pa ...... cranial sonography, and SPECT.
@en
type
label
Detection of presymptomatic Pa ...... cranial sonography, and SPECT.
@en
prefLabel
Detection of presymptomatic Pa ...... cranial sonography, and SPECT.
@en
P2093
P2860
P356
P1433
P1476
Detection of presymptomatic Pa ...... cranial sonography, and SPECT.
@en
P2093
Antje Mueller
Joachim Kropp
Johannes Frasnelli
Katja Cormann
Ulrike Sommer
P2860
P304
P356
10.1002/MDS.20141
P407
P577
2004-10-01T00:00:00Z